Root Financial Partners’s Candel Therapeutics CADL Stock Holding History

Root Financial Partners’s Portfolio CADL Stock Details CADL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$115	Buy	+11	New	+$122	﹤0.01%	3621

Other funds holding CADL

Tanager Wealth Management Goring On Thames, United Kingdom $1.2B AUM 12% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Root Financial Partners's CADL Position: Q3 2026 in Review

Root Financial Partners opened a new position in Candel Therapeutics (CADL) in Q3 2026: 11 shares worth $115. The stake represents ﹤0.01% of the portfolio and ranks #3621 among its holdings.

10 funds tracked by Wall St. Rank hold CADL as of Q3 2026.

Root Financial Partners held 11 shares of Candel Therapeutics worth $115 as of Q3 2026.
Candel Therapeutics was a new Root Financial Partners position in Q3 2026.
Candel Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3621 holding.
10 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.